Northern Trust Corp Clovis Oncology, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.85 $26,066 - $70,751	24,825 Added 9.99%	273,233 $326,000
Q2 2022 Aug 12, 2022	SELL	$0.63 - $2.96 $544,432 - $2.56 Million	-864,178 Reduced 77.67%	248,408 $448,000
Q1 2022 May 13, 2022	SELL	$1.43 - $3.14 $76,901 - $168,859	-53,777 Reduced 4.61%	1,112,586 $2.25 Million
Q4 2021 Feb 08, 2022	BUY	$2.7 - $4.76 $104,530 - $184,283	38,715 Added 3.43%	1,166,363 $3.16 Million
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $225,082 - $321,546	55,439 Added 5.17%	1,127,648 $5.03 Million
Q2 2021 Aug 13, 2021	BUY	$5.02 - $7.05 $488,360 - $685,845	97,283 Added 9.98%	1,072,209 $6.22 Million
Q1 2021 May 12, 2021	BUY	$4.81 - $10.34 $6,974 - $14,993	1,450 Added 0.15%	974,926 $6.85 Million
Q4 2020 Feb 11, 2021	SELL	$4.13 - $6.41 $134,171 - $208,241	-32,487 Reduced 3.23%	973,476 $4.67 Million
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $31,209 - $49,987	6,475 Added 0.65%	1,005,963 $5.87 Million
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $1.74 Million - $2.97 Million	306,508 Added 44.23%	999,488 $6.75 Million
Q1 2020 May 14, 2020	BUY	$3.77 - $11.0 $221,506 - $646,305	58,755 Added 9.26%	692,980 $4.41 Million
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $13,524 - $74,066	4,508 Added 0.72%	634,225 $6.61 Million
Q3 2019 Nov 13, 2019	BUY	$3.93 - $15.35 $3,737 - $14,597	951 Added 0.15%	629,717 $2.48 Million
Q2 2019 Aug 13, 2019	BUY	$12.81 - $25.67 $9,492 - $19,021	741 Added 0.12%	628,766 $9.35 Million
Q1 2019 May 13, 2019	BUY	$17.66 - $30.28 $63,046 - $108,099	3,570 Added 0.57%	628,025 $15.6 Million
Q4 2018 Feb 12, 2019	BUY	$11.63 - $32.67 $4,105 - $11,532	353 Added 0.06%	624,455 $11.2 Million
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $371,324 - $625,575	12,643 Added 2.07%	624,102 $18.3 Million
Q2 2018 Sep 18, 2018	SELL	$42.06 - $62.4 $107,084 - $158,870	-2,546 Reduced 0.41%	611,459 $27.8 Million
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $2.35 Million - $3.48 Million	55,812 Added 10.0%	614,005 $27.9 Million
Q1 2018 May 09, 2018	BUY	$50.12 - $67.72 $902 - $1,218	18 Added 0.0%	558,193 $29.5 Million
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $841,120 - $1.23 Million	-14,580 Reduced 2.55%	558,175 $38 Million
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $38.5 Million - $48.6 Million	572,755	572,755 $47.2 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account